Table 1.
Drug | Number of patients on each drug | |
Group 1 (n=466*) | Group 2 (n=90*) | |
On two or more of the below | 175 | 53 |
Tetrabenazine | 188 | 28 |
Sulpiride | 34 | 16 |
Haloperidol | 66 | 19 |
Olanzapine | 156 | 49 |
Tiapride | 118 | 27 |
Risperidone | 98 | 51 |
Quetiapine | 45 | 8 |
Group 1: patients on antidopaminergic medication throughout the study. Group 2: patients started on antidopaminergic medications part way through the study.
*Some patients were on more than one of the drugs.